SPY312.23+1.71 0.55%
DIA258.42+1.11 0.43%
IXIC10,207.63+53.00 0.52%

Recap: Rite Aid Q1 Earnings

Shares of Rite Aid (NYSE:RAD) moved higher by 6.8% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share were up 71.43% over the past year to ($0.04), which beat the estimate of ($0.38).

Benzinga · -

Shares of Rite Aid (NYSE:RAD) moved higher by 6.8% in pre-market trading after the company reported Q1 results.

Quarterly Results

Earnings per share were up 71.43% over the past year to ($0.04), which beat the estimate of ($0.38).

Revenue of $6,027,000,000 higher by 12.17% from the same period last year, which beat the estimate of $5,610,000,000.

Outlook

Rite Aid hasn't issued any earnings guidance for the time being.

Rite Aid hasn't issued any revenue guidance for the time being.

How To Listen To The Conference Call

Date: Jun 25, 2020

Time: 08:30 AM

ET Webcast URL: https://www.riteaid.com/corporate/investor-relations/presentations

Technicals

52-week high: $23.88

Company's 52-week low was at $5.04

Price action over last quarter: Up 11.98%

Company Overview

Rite Aid Corp is a large retail drugstore chain in the United States. The company reports via two segments: retail pharmacy and pharmacy services. The retail pharmacy segment generates revenue primarily through the sale of prescription drugs, along with an assortment of merchandise that includes over-the-counter medications, health and beauty aids, personal-care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise and numerous other everyday consumables. The pharmacy-services segment relates to EnvisionRx, a fully owned subsidiary that operates as a pharmacy benefit management provider offering a broad range of pharmaceutical services.